145 related articles for article (PubMed ID: 32784646)
1. Homeoprotein Msx1-PIASy Interaction Inhibits Angiogenesis.
Son MJ; Rho SB; Kim K; Oh M; Son C; Song SY; Park K
Cells; 2020 Aug; 9(8):. PubMed ID: 32784646
[TBL] [Abstract][Full Text] [Related]
2. Protein Inhibitor of Activated STAT Y (PIASy) Regulates Insulin Secretion by Interacting with LIM Homeodomain Transcription Factor Isl1.
Yan C; Yu C; Zhang D; Cui Y; Zhou J; Cui S
Sci Rep; 2016 Dec; 6():39308. PubMed ID: 28000708
[TBL] [Abstract][Full Text] [Related]
3. Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation.
Yu X; Chen H; Zuo C; Jin X; Yin Y; Wang H; Jin M; Ozato K; Xu S
FASEB J; 2018 Feb; 32(2):552-567. PubMed ID: 28970247
[TBL] [Abstract][Full Text] [Related]
4. TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions.
Na HJ; Hwang JY; Lee KS; Choi YK; Choe J; Kim JY; Moon HE; Kim KW; Koh GY; Lee H; Jeoung D; Won MH; Ha KS; Kwon YG; Kim YM
Angiogenesis; 2014 Jan; 17(1):179-94. PubMed ID: 24097299
[TBL] [Abstract][Full Text] [Related]
5. PIAS1 negatively regulates ubiquitination of Msx1 homeoprotein independent of its SUMO ligase activity.
Song YJ; Lee H
Mol Cells; 2011 Sep; 32(3):221-6. PubMed ID: 21717107
[TBL] [Abstract][Full Text] [Related]
6. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
Onishi S; Kataoka K
J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
[TBL] [Abstract][Full Text] [Related]
7. Quinazoline analog HMJ-30 inhibits angiogenesis: involvement of endothelial cell apoptosis through ROS-JNK-mediated death receptor 5 signaling.
Lu CC; Chen HP; Chiang JH; Jin YA; Kuo SC; Wu TS; Hour MJ; Yang JS; Chiu YJ
Oncol Rep; 2014 Aug; 32(2):597-606. PubMed ID: 24919794
[TBL] [Abstract][Full Text] [Related]
8. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis.
Nelson V; Davis GE; Maxwell SA
Apoptosis; 2001 Jun; 6(3):221-34. PubMed ID: 11388671
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of VEGF-induced angiogenesis by 2-N, 6-O-sulfated chitosan.
Yu Y; Chen R; Sun Y; Pan Y; Tang W; Zhang S; Cao L; Yuan Y; Wang J; Liu C
Acta Biomater; 2018 Apr; 71():510-521. PubMed ID: 29501817
[TBL] [Abstract][Full Text] [Related]
10. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
11. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling.
Wan L; Zhao Y; Zhang Q; Gao G; Zhang S; Gao Y; Chen X; Qian X
BMC Complement Altern Med; 2019 Dec; 19(1):359. PubMed ID: 31823762
[TBL] [Abstract][Full Text] [Related]
12. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
13. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
14. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
15. Ultrastrong trapping of VEGF by graphene oxide: Anti-angiogenesis application.
Lai PX; Chen CW; Wei SC; Lin TY; Jian HJ; Lai IP; Mao JY; Hsu PH; Lin HJ; Tzou WS; Chen SY; Harroun SG; Lai JY; Huang CC
Biomaterials; 2016 Dec; 109():12-22. PubMed ID: 27639528
[TBL] [Abstract][Full Text] [Related]
16. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
18. Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling.
Wang H; Zhang C; Ning Z; Xu L; Zhu X; Meng Z
Int J Oncol; 2016 Mar; 48(3):1229-41. PubMed ID: 26782953
[TBL] [Abstract][Full Text] [Related]
19. PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein.
Lee H; Quinn JC; Prasanth KV; Swiss VA; Economides KD; Camacho MM; Spector DL; Abate-Shen C
Genes Dev; 2006 Apr; 20(7):784-94. PubMed ID: 16600910
[TBL] [Abstract][Full Text] [Related]
20. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
